The phase 3 AMPLITUDE trial evaluated the safety and efficacy of adding niraparib to abiraterone acetate plus prednisone in patients with mHSPC.
Kim Nguyen Chi, MD, FRCPC
Advertisement
Chi is the chief medical officer of BC Canada and a professor of medicine at the University of British Columbia in Canada.
Articles by Kim Nguyen Chi, MD, FRCPC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
Sildenafil cream for female sexual arousal disorder available to prescribe in select states
3
2025 year in review: Breakthroughs in urologic oncology during a year of unprecedented awareness
4
Evaluating Response to Treatment and Sequencing of Therapies in mCRPC
5
